The legal hammer eventually came down. In 2022, a federal court found that Shkreli schemed to block competition and keep Daraprim's price sky-high. He was ordered to pay back $64.6 million and banned ...

Imagine needing a medication that costs less than a fast-food meal—only to wake up the next day and find it's suddenly priced like a luxury car payment...per single pill. That's exactly what happened ...